Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302273 · ClinicalTrials.gov registry record · NA
Corneal Epithelial Stem Cells and Dry Eye Disease
A NA study of Dry Eye and Dry Eye Syndromes, sponsored by Sloan W. Rush, MD.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03302273 is a NA study of Dry Eye and Dry Eye Syndromes that has completed, run by Sloan W. Rush, MD. The registered enrollment target is 17 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03302273, a NA study of Dry Eye and Dry Eye Syndromes, has completed, sponsored by Sloan W. Rush, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatment, signs of toxicity and adverse effects from the treatment, and for ability of the treatment to improve comfort and restore vision.
Conditions Studied
Interventions
- OTHER Corneal Epithelial Stem Cell Transplant
Study Locations (1)
Texas
- Rush Eye Associates - Amarillo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03302273
The ClinicalTrials.gov registry entry for NCT03302273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower). The listed sponsor is Sloan W. Rush, MD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Corneal Epithelial Stem Cell Transplant is the first listed.
NCT03302273 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03302273 about?
NCT03302273 is a clinical study titled "Corneal Epithelial Stem Cells and Dry Eye Disease". To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatmen...
What is the current status of trial NCT03302273?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-02-01. Estimated completion is 2022-04-01.
What conditions does trial NCT03302273 study?
This clinical trial studies the following conditions: Dry Eye, Dry Eye Syndromes, Blepharitis, Ocular Inflammation, Ocular Surface Disease.
What interventions are being tested in trial NCT03302273?
The interventions under investigation include: Corneal Epithelial Stem Cell Transplant (OTHER).
Who is sponsoring clinical trial NCT03302273?
This trial is sponsored by Sloan W. Rush, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03302273 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.